Skip to main content

AbbVie Inc. Oncology revenue

  • ABBV · NYSE
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$295.03+0.20%Close 13 Nov 2026 · Market value $524.5B

Oncology revenue at AbbVie Inc. came to $1.7B for the quarter to 30 Sep 2026, up 0.8% from a year earlier.

As AbbVie Inc. reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.

By quarter

$1.5BDec 2023$1.5BMar 2024$1.6BJun 2024$1.7BSep 2024$1.7BDec 2024$1.6BMar 2025$1.7BJun 2025$1.7BSep 2025$1.7BDec 2025$1.6BMar 2026$1.7BJun 2026$1.7BSep 2026
AbbVie Inc. Oncology revenue, every reported period
Period endingOncology revenueChange on a yearFiled
30 Sep 2026$1.7Bup 0.8%30 Oct 2026
30 Jun 2026$1.7Bdown 1.6%31 Jul 2026
31 Mar 2026$1.6Bdown 0.1%29 Apr 2026
31 Dec 2025$1.7Bdown 1.6%4 Feb 2026
30 Sep 2025$1.7Bdown 0.3%31 Oct 2025
30 Jun 2025$1.7Bup 2.6%31 Jul 2025
31 Mar 2025$1.6Bup 5.8%25 Apr 2025
31 Dec 2024$1.7Bup 12.1%31 Jan 2025
30 Sep 2024$1.7Bup 11.6%30 Oct 2024
30 Jun 2024$1.6B—25 Jul 2024
31 Mar 2024$1.5B—26 Apr 2024
31 Dec 2023$1.5B—2 Feb 2024
30 Sep 2023$1.5B—27 Oct 2023

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of AbbVie Inc.: Skyrizi revenue · Rinvoq revenue · Botox Therapeutic revenue · Vraylar revenue · Venclexta revenue · Humira revenue · Botox Cosmetic revenue · Imbruvica revenue · Ubrelvy revenue · Qulipta revenue · Creon revenue · Vyalev revenue · Mavyret revenue · Elahere revenue · Juvederm Collection revenue · Linzess/Constella revenue · Ozurdex revenue · Epkinly revenue · Lumigan/Ganfort revenue · Duodopa revenue · Alphagan/Combigan revenue · Immunology revenue · Neuroscience revenue · Aesthetics revenue · financial statements

Every KPI and segment of ABBV, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.